Learning how a new eye disease treatment works in everyday medical care

This study is watching how avacincaptad pegol (Izervay) is used to treat geographic atrophy, a serious form of age-related macular degeneration where cells in the back of the eye break down and cause vision loss. Rather than testing whether the medication works, researchers want to understand how it's actually used in real doctor's offices and clinics, and whether patients experience any side effects. The medication has already been approved by the FDA for this condition.

Avacincaptad pegol is a newly approved treatment, and doctors need real-world information about how it performs when used in typical medical practice and what safety concerns might come up with everyday use.